Global Incontinence Care Products and Devices Market Assessment & Forecast: 2015-2019

Feb 09, 2016, 09:55 ET from ReportBuyer

LONDON, Feb. 9, 2016 /PRNewswire/ -- The new report "Global Incontinence Care Products and Devices Market Assessment, Forecast 2015-2019" by Spearhead Acuity Business Research & Consulting group provides detailed insight into six different geographical regions of North America, Europe, Asia-Pacific, Latin America, Middle-East and Africa. North America continued to lead global incontinence care products and devices market with a share of 32.0% in 2014 that translated into revenues worth US$ 3,152.6 million.

Incontinence is the loss of control or involuntary evacuation of urine or feces that can occur due to multiple causes such as stress, nerve damage of sphincter, urge incontinence, overflow of bladder and pregnancy among some other types. The incontinence market consists of devices for prevention and treatment such as absorbent pads, urology catheters and bags, artificial sphincters, pessaries and clamps and devices that give therapeutic stimulation to nerves. Incontinence occurs in all ages and can affect a person at any point in their lives. Statistics show that close to 8 million people in U.K have suffered from urinary or fecal incontinence. Studies have indicated that over 38% women and 29% men have clinically significant symptoms of incontinence.

The report covers market analysis for a variety of different devices and products such as adult diapers (liners, briefs, pads, guards and drip collection), incontinence catheters (Foley, intermittent and male external catheters), urinary drainage bags, artificial sphincters, incontinence slings, pessaries and clamps and nerve stimulation devices. The incontinence care products and devices market is expected to face several challenges in coming years due to the advent of pharmaceutical products to combat incontinence. The Canadian Urological association and Pfizer Canada are developing a new fellowship program offering support and funding for Canadian urological researchers. Astellas Pharma Canada introduced Myrbetriq, a drug for urge incontinence. The growth stems from a demand for treatment of incontinence which is observed to be on a rise in recent years as there are approximately 27 to 30 million people of all ages suffering from incontinence.

Incontinence care market is challenged greatly by internal substitutes. There is a large variety of treatment methods available such as adult diapers, bulking injections, artificial sphincters, slings & meshes. Drugs such as Anticholinergic agents act on efferent nerves to counteract overactive bladder (OAB) after it occurs. To prevent the occurrence of OAB, therapies should be directed at blocking the afferent nerves that control the bladder. Bulking agents are expected to become a significant substitute treatment for incontinence in coming years and SA-BRC estimates the market to have greatest potential in the adult diapers, neurostimulation and bulking agents segment.

Download the full report: https://www.reportbuyer.com/product/3605160/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer



RELATED LINKS

https://www.reportbuyer.com/product/3605160
https://www.reportbuyer.com/product/3605160


http://www.reportbuyer.com
http://www.reportbuyer.com